By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming Soon.
INTRODUCTION
When certain skin disorders are present, halobetasol topical is used to reduce any redness, itching, swelling, or other pain. Plaque psoriasis can also be treated with it. The drug in question is a corticosteroid (cortisone-like medicine or steroid).
Only a doctor’s prescription is required to purchase this medication. An extremely potent steroid drug called halobetasol (Ultravate) is applied to the skin to reduce swelling and irritation brought on by specific skin diseases. Adults and children who are at least 12 years old— Apply to the skin’s afflicted region twice daily for up to two weeks. Children under the age of 12 should not use this.
Halobetasol is a member of the corticosteroid family. Prostaglandins are chemical messengers that cause the affected area to become red, bloated, and itching. It prevents their formation.
The Global HALOBETASOL market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
In the US, Mayne Pharma introduces Lexette (TM) (halobetasol propionate) foam 0.05%. A new formulation of halobetasol, a strong topical corticosteroid intended for the treatment of plaque psoriasis in adult patients, is known as LEXETTE. It is a conditionally permitted trade name for halobetasol foam.
THE US FOOD AND DRUG ADMINISTRATION APPROVED LEXETTE (FDA) Psoriasis patients will have new treatment options thanks to the sophisticated foam composition LEXETTE. Dermatologists value the foam delivery platform’s reputation for ease of use, lack of greasiness, and stickiness, especially in hair-bearing areas and under garments.
The psoriasis-focused sales staff that now supports LEXETTE will now be able to offer a strong steroid coupled with steroid-free SORILUX® Foam, both of which are frequently used in Protocols for treating psoriasis.
Among the more than 60 products that Mayne Pharma sells directly in the US are four branded dermatology products: FABIOR® (tazarotene) Foam, SORILUX (calcipotriene) Foam, DORYX® MPC (doxycycline hyclate) delayed-release tablets, and LEXETTE (halobetasol propionate) Foam.
TolsuraTM (SUBA®-itraconazole) pills, which the company just launched and for which it recently acquired approval, are used to treat specific fungal infections.A specialist pharmaceutical firm with an ASX listing, Mayne Pharma is committed to using its knowledge of drug delivery to market both branded and generic medications.
More than 100 companies worldwide get contract manufacturing and development services from Mayne Pharma.
